Sustained release polymers sales will expand through 2036, with cellulose derivatives at 42.8% of the polymer type category, matrix systems at 46.5% of release mechanism demand and oral solid dosage at 53.4% of application sales in 2026. The market is projected to record a 7.4% CAGR between 2026 and 2036.